NCBI Taxonomy: 284134
Sarocladium (ncbi_taxid: 284134)
found 222 associated metabolites at genus taxonomy rank level.
Ancestor: Sarocladiaceae
Child Taxonomies: Sarocladium strictum, Sarocladium kiliense, Sarocladium mali, Sarocladium zeae, Sarocladium junci, Sarocladium citri, Sarocladium gamsii, Sarocladium fuscum, Sarocladium oryzae, Sarocladium spirale, Sarocladium sparsum, Sarocladium hominis, Sarocladium glaucum, Sarocladium agarici, Sarocladium cf. zeae, Sarocladium dejongiae, Sarocladium ochraceum, Sarocladium subulatum, Sarocladium terricola, Sarocladium spinificis, Sarocladium sasijaorum, Sarocladium implicatum, Sarocladium bifurcatum, Sarocladium theobromae, Sarocladium mycophilum, Sarocladium attenuatum, Sarocladium graminicola, Sarocladium brachiariae, Sarocladium liquanensis, Sarocladium ferrugineum, unclassified Sarocladium, Sarocladium summerbellii, Sarocladium cf. strictum, Sarocladium bacillisporum, Sarocladium aff. kiliense, Sarocladium bactrocephalum, Sarocladium pseudostrictum, Sarocladium pseudokiliense, Sarocladium cf. zeae KAS965, Sarocladium cf. strictum JY03-006, Sarocladium cf. bacillisporum CBS 109351
Penicillin G
Penicillin G is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms. Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Penicillin V
Penicillin V is narrow spectrum antibiotic used to treat mild to moderate infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered orally. Penicillin V may also be used in some cases as prophylaxis against susceptible organisms. Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Cephalosporin C
C16H21N3O8S (415.10493060000005)
Cephalosporin C is an antibiotic of the cephalosporin class. It was isolated from fungi of the genus Acremonium and first characterized in 1961. Although not a very active antibiotic itself, synthetic analogs of cephalosporin C, such as cefalotin, became some of the first marketed cephalosporin antibiotic drugs. (Wikipedia) D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Deacetylcephalosporin C
A 3-hydroxymethylcephalosporin having a (5-amino-5-carboxypentanoyl)amino group at the 7-position. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
SYNNEMATIN B
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Deacetoxycephalosporin C
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Adicillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Penicillin G
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Cephalosporin C
C16H21N3O8S (415.10493060000005)
A cephalosporin antibiotic carrying a 3-acetoxymethyl substituent and a 6-oxo-N(6)-L-lysino group at position 7. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
xenovulene A
A sesquiterpenoid based on a humulene skeleton. It is isolated from Sarocladium strictum and has been shown to exhibit inhibitory activity against GABA receptor.
Penicillin V
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Isopenicillin N
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-chloro-7-hydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one
1,2-dihydroxy-4,8,11-trimethyl-9-oxatricyclo[6.2.1.0²,⁶]undec-4-ene-3,10-dione
12,14-dihydroxy-3-methyl-4,5,6,7,8,10-hexahydro-3h-2-benzoxacyclododecine-1,9-dione
(6r,7r)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2-[2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
[7-hydroxy-2-(6-hydroxyheptyl)-4-oxochromen-5-yl]acetic acid
(2s,5r,6r)-6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2e)-3-(4-methoxy-5-methyl-6-oxopyran-2-yl)but-2-enoic acid
3-(4-methoxy-5-methyl-6-oxopyran-2-yl)but-2-enoic acid
6,7,12-trihydroxy-4,13-bis(1-hydroxyhexa-2,4-dien-1-ylidene)-2,6,9,11-tetramethyl-8-oxatricyclo[7.4.0.0²,⁷]tridec-11-ene-3,5,10-trione
(3s)-12,14-dihydroxy-3-methyl-4,5,6,7,8,10-hexahydro-3h-2-benzoxacyclododecine-1,9-dione
1-heptyl-4-(1-heptyl-6,7,8-trihydroxy-3-oxo-1,4-dihydro-2-benzopyran-4-yl)-6,7,8-trihydroxy-1,4-dihydro-2-benzopyran-3-one
2-[(1e,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9bs,11ar)-2-(acetyloxy)-4,5,7-trihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
(2s,5r,6r)-6-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2e)-3-(3-heptyloxiran-2-yl)-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one
3-(3-heptyloxiran-2-yl)-1-(2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl)prop-2-en-1-one
(6r,7s)-7-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2-[2-(acetyloxy)-4,5,7-trihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9bs,11ar)-2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
methyl 2-{6-hydroxy-8-methoxy-1-methyl-3,5-dioxofuro[3,4-c]isochromen-1-yl}acetate
(2r,5r,6r)-5-hydroxy-2-[(1s,2e)-1-hydroxybut-2-en-1-yl]-6-[(1e)-prop-1-en-1-yl]-5,6-dihydro-2h-pyran-3-carboxylic acid
(6s)-1,4-dimethyl-6-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)piperazine-2,3,5-trione
15-hydroxy-5,8,8,12-tetramethyl-13,19-dioxatetracyclo[12.5.1.0²,¹².0¹⁷,²⁰]icosa-5,9,14-trien-16-one
(3r,11r,16as)-11-benzyl-9-hydroxy-6-methyl-3-propyl-3h,4h,8h,11h,14h,15h,16h,16ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclotetradecane-1,7,12-trione
5-hydroxy-2-(1-hydroxybut-2-en-1-yl)-6-(prop-1-en-1-yl)-5,6-dihydro-2h-pyran-3-carboxylic acid
(2s,5r,6r)-6-[(2-{[(2s)-2-amino-2-carboxyethyl]sulfanyl}-1-hydroxyethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(6r,7r)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9br,11ar)-2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
6-chloro-2-[(7-formyl-6-hydroxy-1,4-dimethoxy-3-oxo-1h-2-benzofuran-5-yl)methoxy]-4a-hydroxy-2,5,5,8a-tetramethyl-hexahydronaphthalene-1-carboxylic acid
(1s,3r,6r,7r,10e,14r)-6-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7,11-dimethyl-18-oxatricyclo[12.3.1.0³,⁷]octadec-10-ene-2,16-dione
5-{[(1r)-1-amino-1-{[(1s)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid
C14H25N3O6S (363.14639900000003)
(2e)-3-[(2r,3r)-3-heptyloxiran-2-yl]-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one
{7-hydroxy-2-[(6s)-6-hydroxyheptyl]-4-oxochromen-5-yl}acetic acid
2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9bs,11ar)-2-(acetyloxy)-4,5,7-trihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
(1r,2r,4z,6s,7s,9s,13z)-6,7,12-trihydroxy-4,13-bis[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-2,6,9,11-tetramethyl-8-oxatricyclo[7.4.0.0²,⁷]tridec-11-ene-3,5,10-trione
methyl 2-[(1s)-6-hydroxy-8-methoxy-1-methyl-3,5-dioxofuro[3,4-c]isochromen-1-yl]acetate
(5s)-5-[(1s,2z,4e)-1-hydroxyhexa-2,4-dien-1-yl]oxolan-2-one
(3s,6r)-6,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
6-({2-[(2-amino-2-carboxyethyl)sulfanyl]-1-hydroxyethylidene}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2s,5r,6r)-6-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(2s,5r,6r)-6-[(1-hydroxy-2-phenoxyethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(1r,2r,4as,6s,8ar)-6-chloro-2-{[(1s)-7-formyl-6-hydroxy-1,4-dimethoxy-3-oxo-1h-2-benzofuran-5-yl]methoxy}-4a-hydroxy-2,5,5,8a-tetramethyl-hexahydronaphthalene-1-carboxylic acid
(2s,6s,7r,9s,13z)-4-[(2e,4e)-hexa-2,4-dienoyl]-6,7,12-trihydroxy-13-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-2,6,9,11-tetramethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-3,11-diene-5,10-dione
(1r,2r,4z,6s,7s,9s,13z)-6,7,10-trihydroxy-4,13-bis[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-2,6,9,11-tetramethyl-8-oxatricyclo[7.4.0.0²,⁷]tridec-10-ene-3,5,12-trione
7-hydroxy-3,4,9-trimethoxy-1-methylbenzo[c]chromen-6-one
7-[(5-amino-5-carboxy-1-hydroxypentylidene)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(1r,2s,6s,8s,11r)-1,2-dihydroxy-4,8,11-trimethyl-9-oxatricyclo[6.2.1.0²,⁶]undec-4-ene-3,10-dione
(3r,6r)-5-hydroxy-1-methyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)-6h-pyrazin-2-one
C19H26N2O3S2 (394.13847660000005)
2-[2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
11-benzyl-9-hydroxy-6-methyl-3-propyl-3h,4h,8h,11h,14h,15h,16h,16ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclotetradecane-1,7,12-trione
(3r,6r)-5-hydroxy-1-methyl-6-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3,6-bis(methylsulfanyl)-3h-pyrazin-2-one
C19H26N2O3S2 (394.13847660000005)
(2s,5r,6r)-6-[(hydroxymethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C9H12N2O4S (244.05177519999998)
4,7-dihydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one
6,7,10-trihydroxy-4-(1-hydroxyhexa-2,4-dien-1-ylidene)-13-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-2,6,9,11-tetramethyl-8-oxatricyclo[7.4.0.0²,⁷]tridec-10-ene-3,5,12-trione
2-(2-isopropylazirin-1-yl)-1-methyl-9h-purin-6-one
C11H13N5O (231.11200480000002)